SIMPLEX TRADING, LLC - NEOS THERAPEUTICS INC ownership

NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 59 filers reported holding NEOS THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
SIMPLEX TRADING, LLC ownership history of NEOS THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$0100
+51.5%
0.00%
Q2 2020$0660.0%0.00%
Q1 2020$0
-100.0%
66
-96.1%
0.00%
Q2 2019$2,000
-96.7%
1,706
-86.5%
0.00%
Q3 2018$61,000
+1120.0%
12,657
+1419.4%
0.00%
Q2 2018$5,000
-93.9%
833
-89.7%
0.00%
-100.0%
Q4 2017$82,000
-30.5%
8,125
-37.2%
0.00%
-20.0%
Q3 2017$118,000
+521.1%
12,933
+380.6%
0.01%
+400.0%
Q2 2017$19,0002,6910.00%
Other shareholders
NEOS THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
DSC Advisors, L.P. 1,043,770$7,620,0002.51%
Stonepine Capital Management, LLC 565,100$4,125,0002.23%
DAFNA Capital Management LLC 209,873$1,532,0001.09%
Ghost Tree Capital, LLC 500,000$3,650,0000.76%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,459,195$10,652,0000.57%
PURA VIDA INVESTMENTS, LLC 150,000$1,095,0000.44%
J. Goldman & Co LP 845,000$6,169,0000.33%
ESSEX INVESTMENT MANAGEMENT CO LLC 191,729$1,400,0000.20%
Opaleye Management Inc. 50,000$365,0000.15%
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 50,000$365,0000.15%
View complete list of NEOS THERAPEUTICS INC shareholders